Evaluating Response to Cancer Therapy
6 Questions
3 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary challenge in individualizing therapy for patients?

  • Patients' heterogeneous responses to treatment (correct)
  • Radiopharmaceutical agents' limited availability
  • Lack of effective chemotherapy regimens
  • Inability to assess treatment response rapidly
  • Why is it insufficient to rely solely on tumor volume changes to evaluate response to antitumor therapy?

  • Patients may develop toxicity and side effects before changes are evident (correct)
  • Radiopharmaceutical agents are not effective in predicting response
  • Tumor volume changes are difficult to measure
  • Changes in tumor volume occur too slowly
  • What is the benefit of using radiopharmaceutical agents like Gallium or FDG in evaluating response to therapy?

  • They can predict response to treatment as early as after 1-3 cycles of chemotherapy (correct)
  • They are not effective in detecting response to chemotherapy
  • They can only be used after multiple cycles of chemotherapy
  • They are only effective in detecting response in lymphoma
  • What is the purpose of evaluating response to therapy?

    <p>To rapidly assess whether a chosen treatment strategy is effective</p> Signup and view all the answers

    What is a limitation of using CT or MRI studies to evaluate response to therapy?

    <p>They may not reveal response quickly enough to prevent patient harm</p> Signup and view all the answers

    What is demonstrated in the follow-up study (b) in a patient with non-Hodgkin's lymphoma?

    <p>An excellent response to chemotherapy</p> Signup and view all the answers

    More Like This

    Cancer Therapy and Treatment Quiz
    5 questions
    Cancer Chemotherapy
    40 questions
    Tratamiento del Cáncer de Esófago
    30 questions
    Use Quizgecko on...
    Browser
    Browser